NEW ZEALAND DATA SHEET 1. …

Page 2 of 9 about to undergo dental procedures or minor upper respiratory tract surgery or instrumentation. Oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or

Tags:

  Dental

Information

Documents from same domain

SEPTANEST Articaine hydrochloride 4% with …

www.medsafe.govt.nz

SEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.

  Articaine

ADVANTAN Presentation Uses - Medsafe

www.medsafe.govt.nz

ADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.

  Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate

LOXALATE 1. Product Name - Medsafe Home Page

www.medsafe.govt.nz

Page 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.

  Risks, Combination

DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …

www.medsafe.govt.nz

New Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …

  Sheet, Data, Data sheet, Clexane

BOOSTRIX - Medsafe Home Page

www.medsafe.govt.nz

1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.

  Information, Boostrix

NEW ZEALAND DATA SHEET - Medsafe

www.medsafe.govt.nz

NEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a

  Cymevene

Edition Draft - Medsafe

www.medsafe.govt.nz

Part 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for

  Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice

Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …

www.medsafe.govt.nz

New Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …

  Product, Name, Sheet, Data, Data sheet 1 product name

NEW ZEALAND DATA SHEET MESTINON® - Medsafe

www.medsafe.govt.nz

NEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to

  Myasthenia, Gravis, Myasthenia gravis, Mestinon

DATA SHEET PREDNISONE - Medsafe

www.medsafe.govt.nz

• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since

  Myasthenia, Gravis, Myasthenia gravis, Prednisone

Related documents

Policy on Acute Pediatric Dental Pain Management

www.aapd.org

AMERICAN ACADEMY OF PEDIATRIC DENTISTRY ORAL HEALTH POLICIES 99 Purpose The American Academy of Pediatric Dentistry (AAPD) recog- nizes that children vary greatly in their cognitive and emo-

  Management, Children, Dental

Primary FRCA Syllabus

www.frca.co.uk

Anaesthesia in special circumstances Principles of obstetric anaesthesia Principles of the care of children (excluding neonates and infants) undergoing

  Syllabus, Primary, Children, Of children, Craf, Undergoing, Primary frca syllabus

New Zealand Data Sheet - Medsafe

www.medsafe.govt.nz

2 Tranexamic acid film TRANEXAMIC ACID TABLETS -coated tablets 500 mg. Hereditary angioneurotic oedema. For the reduction of peri – and post -operative blood loss and the need for blood transfusion

  Acid, Tranexamic acid, Tranexamic

Related search queries